Cegedim SA (CGM) EUR0.9528

Sell:€11.80Buy:€11.90€0.20 (1.67%)

Prices delayed by at least 15 minutes
Sell:€11.80
Buy:€11.90
Change:€0.20 (1.67%)
Prices delayed by at least 15 minutes
Sell:€11.80
Buy:€11.90
Change:€0.20 (1.67%)
Prices delayed by at least 15 minutes

Company Information

About this company

Cegedim SA is a France-based company that produces and distributes data and services linked to medical information and customer relationship management (CRM) activities for the Sales and Marketing Departments in the Healthcare and Life Sciences sectors. Cegedim is also a manufacturer of medical and para-medical management software, and designs management applications dedicated to the health insurance sector. The Company’s falls into three sectors: Life Sciences which comprises solutions specifically designed for pharmaceutical companies; Healthcare professionals designed for doctors, pharmacists and paramedics, and Healthcare Insurance, which is designed for health insurance providers and for companies of any sectors. The Company operates through Webstar Health and a number of subsidiaries. Cegedim SA is present in approximately 80 countries around the world.

Key people

Jean-Claude Labrune
Chairman of the Board, Chief Executive Officer
Laurent Labrune
Deputy Managing Director, Executive Director
Pierre Marucchi
Deputy Managing Director, Director - Representative of FCB
Catherine Abiven
Non-Executive Director
Sandrine Debroise
Non-Executive Director
Nicolas Giraud
Non-Executive Director - Representative of GERS
Aude Labrune-Marysse
Non-Executive Director
Jean - Pierre Cassan
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    France
  • Sector
    Technology
  • Industry
    Software & Programming
  • ISIN
    FR0000053506
  • Market cap
    €169.17m
  • Employees
    6,769
  • Shares in issue
    14.10m
  • Exchange
    Euronext Paris
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.